Key result
Bioinformatics analysis identified five hub genes (COL1A2, COL6A3, COL15A1, CLU, and LUM) and related microRNAs as potential diagnostic biomarkers and therapeutic targets for diabetic nephropathy.
Why the study?
To provide molecular markers and potential targeted molecular therapy for diabetic nephropathy by screening hub genes based on bioinformatic analysis.
Bioinformatics analysis identified five hub genes (COL1A2, COL6A3, COL15A1, CLU, LUM) and associated microRNAs as potential biomarkers and therapeutic targets for diabetic nephropathy.
Answers are grounded in this paper and cite their sources.
Potential biomarkers identified but not ready for use; leaves open clinical validation in diabetic nephropathy.
Background: To provide molecular markers and potential targeted molecular therapy for diabetic nephropathy by screening hubgenes based on bioinformatic analysis. Results: We found 91 differentially expressed genes (DEGs) between diabetic nephropathy tissues and normal kidney tissues. Majority DEGs were significantly enriched in the extracellular matrix structural constituent, collagen-containing extracellular matrix. KEGG pathway analysis showed that most of DEGs participated in PI3K-Akt signaling pathway, AGE-RAGE signaling pathway in diabetic complications. Five high relevant sub-networks and the top 16 genes according to 12 topological algorithms were screened out and also five co-expressed gene modules were identified by WGCNA. Eventually, 5 hub genes were identified by taking the intersection which might be involved in the progression of DN. And 11 microRNAs were associated with related genes in WebGestalt. Conclusions: We identified five hub genes, namely COL1A2, COL6A3, COL15A1, CLU and LUM, and their related microRNAs(especially miR29 and miR196), which might be used as diagnostic biomarkers and therapeutic targets for diabetic nephropathy.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2020) studied Diabetic nephropathy (n=140). Diabetic nephropathy vs. Normal kidney samples was evaluated on Identification of differentially expressed genes and hub genes. Bioinformatics analysis identified five hub genes (COL1A2, COL6A3, COL15A1, CLU, and LUM) and related microRNAs as potential diagnostic biomarkers and therapeutic targets for diabetic nephropathy.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: